Mesa Laboratories Stock News

Lakewood, CO, July 06, 2020 (GLOBE NEWSWIRE) -- - Mesa Laboratories, Inc. (MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regul

Parametric Portfolio Associates LLC increased its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 19.1% during the first quarter, according to the company in its most recent disclosure with the S

Balyasny Asset Management LLC lowered its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 62.9% in the first quarter, according to the company in its most recent Form 13F filing with th

Mackenzie Financial Corp cut its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB) by 42.9% in the first quarter, HoldingsChannel.com reports. The fund owned 1,000 shares of the medical instruments suppl

The issuance of the additional shares will result in additional gross proceeds of approximately $20.3 million to Mesa Labs, and gross proceeds for the offering as a whole of approximately $155.3 milli

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev

In addition, Mesa Labs has granted the underwriters a 30-day option to purchase up to 90,000 additional shares. The offering is expected to settle on June 12, 2020, subject to customary closing cond

In addition, Mesa Labs expects to grant the underwriters a 30-day option to purchase up to an additional $15 million of shares. Mesa Labs intends to use the net proceeds from the offering for general

The Global Sterilization Monitoring Market will grow by $ 259.99 bn during 2020-2024

Mesa Labs (MLAB) delivered earnings and revenue surprises of -36.45% and -0.85%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Shares of Mesa Laboratories (NASDAQ:MLAB) were unchanged after the company reported Q4 results.Quarterly Results Earnings per share decreased 26.29% over the past year to $1.29, which beat the estimat

LAKEWOOD, Colo., June 01, 2020 -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q20”) and full year ended March 31, 2020 (“FY20”)..